Voices
EOS Calls Experts to Discuss Immunotherapy in Early NSCLC
EOS/ LinkedIn

EOS Calls Experts to Discuss Immunotherapy in Early NSCLC

Emirates Oncology Society (EOS) shared on LinkedIn:

“Join Emirates Oncology Society experts for Role of Immunotherapy in the Management of Early NSCLC Non Oncogenetic Mutations Webinar.

  •  Thursday, 17th September 2026/ Virtual / 2CME Hours
  •  🇦🇪 08:00 PM / 🇺🇸 12:00 PM (NY) / 🇰🇼 07:00 PM / 🇬🇧 05:00 PM
  •  Register Here.
  •  Moderator: Dr. Dalia Elshorbagy
  •  Speaker: Dr Fathi Azribi / Dr. Saeed Rafii
  •  Endorsed by: Emirates Oncology Society
  • Sponsored by: AstraZenecav.”

EOS Calls Experts to Discuss Immunotherapy in Early NSCLC

Don’t Miss the Chance to Be Among the Top 3 Best Abstract Award Winners at EOS 2026 – Emirates Oncology Society

EOS Calls Experts to Discuss Immunotherapy in Early NSCLC

AstraZenecav cancer Dalia Elshorbagy Emirates Oncology Society EOS Fathi Azribi immunotherapy Lung cancer NSCLC OncoDaily Oncology Saeed Rafii